Scan Comparison: Oct 2025 vs Apr 2026

Parenchymal Changes

Lymph Nodes

Other Findings

Summary Interpretation

1. Active disease has substantially reduced — widespread bilateral TIB nodules and cavitating consolidations have largely resolved.
2. Residual low-grade activity persists — focal GGO + TIB in the left lower lobe suggests some ongoing endobronchial spread or slow resolution; this warrants continued ATT rather than stopping.
3. Fibrotic scarring has set in — multifocal traction bronchiectasis and fibrotic changes are now visible, which are expected permanent sequelae of TB; these will not resolve with further treatment.
4. Lymphadenopathy is stable/calcifying — consistent with healing granulomatous disease.
5. Cavitation has cleared — a favorable prognostic sign, as open cavities are associated with higher bacillary burden and drug resistance risk.

⚠️ The residual focal TIB opacities in April 2026 should be correlated with sputum culture/AFB status and clinical symptoms. If the patient remains sputum-negative and asymptomatic, it may reflect slow radiological lag behind microbiological clearance. The treating physician (Dr Vijay Kumar) should assess whether ATT duration extension is warranted.

Full Clinical Summary — Sanskar Kumar, 21M

Three-Point Evidence

What This Means Together

Practical Assessment

Key Points for the Treating Doctor

1. Standard pulmonary TB requires 6 months of ATT (2HRZE / 4HR). If started around Oct 2025, the course would complete around Apr 2026 — which is exactly when this follow-up HRCT was done.
2. With no symptoms + negative sputum, the residual focal opacity on HRCT alone is not an indication to extend ATT per WHO and national guidelines. CT findings should not override bacteriological and clinical cure.
3. A repeat sputum AFB or CBNAAT (GeneXpert) around the end of treatment (if not already done) would formally confirm cure.
4. The patient should be monitored for late complications of pulmonary TB: post-TB bronchiectasis, aspergilloma in residual cavities (none visible here), and restrictive lung function.

⚠️ This analysis is for informational purposes. The final decision on ATT completion or extension rests with Dr. Vijay Kumar based on full clinical assessment.

Fitness for International Travel & Medical Education

What the Evidence Supports ✅

Important Caveats to Address First

• UK, Australia, Canada, New Zealand require an IGRA or chest X-ray for visa from high-TB-burden countries (India is on this list)
• The destination country's embassy medical requirements must be checked separately
• A "treated TB" history with documentation is usually acceptable, but must be declared

• Documented completion of TB treatment
• A fitness certificate from the treating physician (Dr. Vijay Kumar)
• Some institutions require a negative IGRA or repeat sputum before allowing contact with immunocompromised patients

Bottom Line

If Dr. Vijay Kumar formally declares treatment complete and issues a fitness certificate, Sanskar is medically fit for travel and clinical postings. The imaging and smear results strongly support this. The residual CT changes are sequelae, not active disease.

• Diagnosis: Pulmonary TB
• Treatment: ATT completed (dates)
• Current status: Treated, non-infectious, fit for clinical duties

• Hospital letterhead — Jay Prabha Medanta, Patna
• Patient details — Sanskar Kumar, 21M, UHID BP00374959
• Investigations table — CECT Oct 2025, Sputum AFB Dec 2025 (Negative), HRCT Apr 2026
• Treatment record — ATT Oct 2025 – Apr 2026, outcome: Completed/Cured
• Fitness declaration — explicitly states non-infectious, fit for international travel, medical education, clinical postings, and unrestricted professional activity
• Disclaimer — residual CT changes are post-TB sequelae, not active disease
• Issuing doctor — Dr. Vijay Kumar, with signature space and date

Important: Dr. Vijay Kumar must review, physically sign, and stamp this certificate before it is used for official purposes (visa, university admission, hospital registration). A doctor's wet signature and hospital seal are required for it to be legally valid.

Additional Tests — Are They Needed?

For Treatment Confirmation (Medical Standpoint)

For International Travel / Visa

For Clinical Posting at a Medical School/Hospital

Practical Priority List

1. GeneXpert sputum — do this now, before the certificate is finalised, to close the microbiological documentation gap
2. LFTs — one final check post-ATT
3. Know the destination country — the specific visa/entry TB requirements vary significantly by country; embassy website or IOM panel physician consultation will define exactly what is needed
4. Pre-clinical posting bloods — HIV, HBsAg, vaccination records should be compiled regardless of the TB history

The destination country matters most here. If you share where Sanskar is travelling for his medical education, I can give the exact requirements for that country.

Requirements for Russia — MBBS Medical Student

Student Visa (Before Travel)

On Arrival in Russia — Mandatory Medical Examination

For Dormitory/University Residence

"Certificate of absence of tuberculosis, HIV, hepatitis B with a therapist's note that there are no contraindications for living in the dormitory — with notarially certified Russian translation (valid 6 months)."

1. ✅ Fitness certificate — already created, covers TB
2. HIV negative certificate — get tested in India before travel
3. HBsAg (Hepatitis B) negative certificate — get tested in India before travel
4. Notarially certified Russian translation of all three documents

Complete Pre-Travel Checklist for Russia

Assessment: Are These Certificates Sufficient for Russia?

What the Certificates Have ✅

Gap Analysis — What's Still Needed

• Passport number (critical for embassy)
• Patient photograph with doctor's stamp
• Specific treatment completion date (16 April 2026)
• "No further anti-tubercular treatment is required" — important for dormitory admission
• Cleaner, more detailed clinical narrative

Russian Visa Process Summary for Sanskar

On Arrival in Russia (within 30 days)